Summit Financial Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Summit Financial Group's AMGN Position: Q1 2024 in Review
Summit Financial Group reduced its Amgen (AMGN) stake by 2.7% in Q1 2024, selling an estimated $10.5K and leaving 1,287 shares worth $366K. The position accounts for 0.13% of the portfolio, ranked #139.
Summit Financial Group first reported a position in AMGN in Q2 2017 and has held it in 27 quarters since. The position peaked at $381K in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.
- Summit Financial Group held 1,287 shares of Amgen worth $366K as of Q1 2024.
- Summit Financial Group sold 36 Amgen shares in Q1 2024, an estimated $10.5K.
- Amgen made up 0.13% of Summit Financial Group's portfolio in Q1 2024, its #139 holding.
- Summit Financial Group first reported a position in Amgen in Q2 2017 and has held it in 27 quarters since.
- Summit Financial Group's Amgen position peaked at $381K in Q4 2023.
- 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.
Based on Summit Financial Group's 13F filing for Q1 2024, filed 5 Apr 2024.